I-Mab OverviewLatest common stock for IMAB: $19K.
Get informed when a big investor buys or sells
+ Follow
Latest change versus the prior comparable period (same company). Positive growth indicates new issuance/dilution; negative growth indicates reductions/buybacks.
As of the most recent data (June 2025), IMAB shows a common stock of $19K. That compares with $19K in the prior-year period — up 0.0% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, IMAB's common stock is now $19K (was $19K) — essentially flat versus a year earlier. Pairing that YoY change with peer averages gives a clearer picture of whether I-Mab is outperforming or lagging.
Tracking IMAB's common stock over time shows whether I-Mab is scaling, shrinking, or reshaping that part of the business. The current reading is $19K That compares with $19K in the prior-year period — up 0.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this common stock page, Stockcircle has I-Mab's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect common stock (currently $19K) with ownership activity and broader fundamentals.
I-Mab's common stock is $19K; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.
